BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PHN-012 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PHN-012\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07127874-2684@assetmemo.bio
DTSTAMP:20261121T005420Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:PHN-012: Phase 1 readout est. (NCT07127874)
DESCRIPTION:PHN-012\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study
  of PHN-012 in Patients With Advanced Solid Tumors\nEstimated primary comp
 letion: September 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/phn-012#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT07127874
URL:https://assetmemo.bio/drug/phn-012#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
